0
Article |

Thallium Poisoning:  Report of Two Cases FREE

MICHEL D. STEIN, M.D.; MEYER A. PERLSTEIN, M. D.
[+] Author Affiliations

Submitted for publication Dec. 18, 1958.


AMA Am J Dis Child. 1959;98(1):80-85. doi:10.1001/archpedi.1959.02070020082010.
Text Size: A A A
Published online

A survey of the admissions to the Cook County Hospital, Chicago, for the five-year period from 1954 to 1958 reveals that in a total of 396,220 admissions (excluding psychiatric cases) only two cases of thallium poisoning were recognized. While thallium poisoning is not common, neither is it so rare that it should be seen only twice in 396,000 admissions to a hospital catering to the less privileged classes. This suggests that its clinical manifestations are at times confusing and that it may simulate other conditions. The suspected diagnosis can be confirmed only by biochemical analysis. It is not the purpose of this paper to review the literature regarding thallium poisoning, but rather to add two patients whose presenting sign was ataxia. We wish to point out the salient features and the possible sources of diagnostic confusion and to report on the use of dimercaprol (BAL) and trihexyphenidyl (Artane) in therapy

REFERENCES

Grossman, H.:  Thallotoxicosis: Report of a Case and a Review , Pediatrics 16:868-872, 1956;.
Munch, J. C.:  Human Thallotoxicosis , J.A.M.A. 102:1929, 1934;.
Munch, J. C.; Ginsburg, H. M., and Nixon, C. E.:  The 1932 Thallotoxicosis Outbreak in California , J.A.M.A. 100:1315, 1933;.
 Thallotoxicosis: A Recurring Problem, Report of Council on Drugs , J.A.M.A. 165:1566, 1957;.
Heyroth, F. F.:  Thallium: A Review and Summary of Medical Literature, Supp. 197 , Public Health Rep. , 1947;.
Mazzei, E. S., and Schaposnik, F.:  Subacute Poisoning by Thallium Treated with BAL , Brit. M. J. 2:791, 1949;.
Chamberlain, P. N.; Stavinoha, W. B.; Davis, H.; Kniker, W. T., and Panos, T. C.:  Thallium Poisoning , Pediatrics 22:1170, 1958;.
Pardo-Costello, V.; Mestre, J. J., and Rio, E.:  Tinea of the Scalp: Treatment with Thallium Salts , Arch. Dermat. & Syph. 19:409, 1929;.
McCarthy, L.: Diagnosis and Treatment of Diseases of the Hair , St. Louis, The C. V. Mosby Company, 1940;.
Munch, J. C.:  The Toxicity of Thallous Sulfate , J. Am. Pharm. A. 17:1086, 1928;.
Furmanski, A. R.:  BAL Therapy of Severe Peripheral Neuropathies , Arch. Neurol. & Psychiat. 60:270, 1948;.
Longcope, W. T., and Luetscher, J. A., Jr.:  Use of BAL (British Anti-Lewisite) in Treatment of Injurious Effects of Arsenic, Mercury and Other Metallic Poisons , Advances Int. Med. 31: 545, 1949;.
Grulee, C. G., Jr., and Clark, E. H.:  Thallotoxicosis in a Preschool Nursery , Am. J. Dis. Child. 81:47, 1951;.
Fairweather, M. J.; Stovell, V.; Santiago, P.; Adams, K. P.; Davis, J., and Campbell, W.:  Thallium Poisoning of Children in Texas , Tex. J. Med. 51:466, 1955;.
Modell, W.; Gold, H., and Cattell, M.:  Pharmacological Observations on BAL by Intramuscular Injection in Man , J. Clin. Invest. 25: 480, 1946;.
Sulzberger, M. B.; Baer, R. L., and Kanof, A.:  Studies on the Toxicity of BAL on Percutaneous and Parenteral Administration , J. Clin. Invest. 25:474, 1946;.
Ellenbogen, B. K.:  Artane in the Treatment of Parkinsonism , Lancet 1:1034, 1950;.
Ferguson, F. R., and Liversedge, L. A.:  Current Therapeutics: XXXIV. The Management of Parkinsonism and Allied Extrapyramidal Diseases , Practitioner 165:437, 1950;.
Corbin, K. B.:  Trihexyphenidyl: Evaluation of the New Agent in the Treatment of Parkinsonism , J. A. M. A. 141:377, 1949;.
Bredemann, W.:  Zur histopathologie der Thalliumvergiftung im Bereich des Nervensystems , Arch. Psychiat. 192:393, 1954;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Grossman, H.:  Thallotoxicosis: Report of a Case and a Review , Pediatrics 16:868-872, 1956;.
Munch, J. C.:  Human Thallotoxicosis , J.A.M.A. 102:1929, 1934;.
Munch, J. C.; Ginsburg, H. M., and Nixon, C. E.:  The 1932 Thallotoxicosis Outbreak in California , J.A.M.A. 100:1315, 1933;.
 Thallotoxicosis: A Recurring Problem, Report of Council on Drugs , J.A.M.A. 165:1566, 1957;.
Heyroth, F. F.:  Thallium: A Review and Summary of Medical Literature, Supp. 197 , Public Health Rep. , 1947;.
Mazzei, E. S., and Schaposnik, F.:  Subacute Poisoning by Thallium Treated with BAL , Brit. M. J. 2:791, 1949;.
Chamberlain, P. N.; Stavinoha, W. B.; Davis, H.; Kniker, W. T., and Panos, T. C.:  Thallium Poisoning , Pediatrics 22:1170, 1958;.
Pardo-Costello, V.; Mestre, J. J., and Rio, E.:  Tinea of the Scalp: Treatment with Thallium Salts , Arch. Dermat. & Syph. 19:409, 1929;.
McCarthy, L.: Diagnosis and Treatment of Diseases of the Hair , St. Louis, The C. V. Mosby Company, 1940;.
Munch, J. C.:  The Toxicity of Thallous Sulfate , J. Am. Pharm. A. 17:1086, 1928;.
Furmanski, A. R.:  BAL Therapy of Severe Peripheral Neuropathies , Arch. Neurol. & Psychiat. 60:270, 1948;.
Longcope, W. T., and Luetscher, J. A., Jr.:  Use of BAL (British Anti-Lewisite) in Treatment of Injurious Effects of Arsenic, Mercury and Other Metallic Poisons , Advances Int. Med. 31: 545, 1949;.
Grulee, C. G., Jr., and Clark, E. H.:  Thallotoxicosis in a Preschool Nursery , Am. J. Dis. Child. 81:47, 1951;.
Fairweather, M. J.; Stovell, V.; Santiago, P.; Adams, K. P.; Davis, J., and Campbell, W.:  Thallium Poisoning of Children in Texas , Tex. J. Med. 51:466, 1955;.
Modell, W.; Gold, H., and Cattell, M.:  Pharmacological Observations on BAL by Intramuscular Injection in Man , J. Clin. Invest. 25: 480, 1946;.
Sulzberger, M. B.; Baer, R. L., and Kanof, A.:  Studies on the Toxicity of BAL on Percutaneous and Parenteral Administration , J. Clin. Invest. 25:474, 1946;.
Ellenbogen, B. K.:  Artane in the Treatment of Parkinsonism , Lancet 1:1034, 1950;.
Ferguson, F. R., and Liversedge, L. A.:  Current Therapeutics: XXXIV. The Management of Parkinsonism and Allied Extrapyramidal Diseases , Practitioner 165:437, 1950;.
Corbin, K. B.:  Trihexyphenidyl: Evaluation of the New Agent in the Treatment of Parkinsonism , J. A. M. A. 141:377, 1949;.
Bredemann, W.:  Zur histopathologie der Thalliumvergiftung im Bereich des Nervensystems , Arch. Psychiat. 192:393, 1954;.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.